235 related articles for article (PubMed ID: 24836404)
21. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin.
Peng X; Zhou Y; Han K; Qin L; Dian L; Li G; Pan X; Wu C
Drug Des Devel Ther; 2015; 9():4209-18. PubMed ID: 26345516
[TBL] [Abstract][Full Text] [Related]
22. Cubosomes in Drug Delivery-A Comprehensive Review on Its Structural Components, Preparation Techniques and Therapeutic Applications.
Sivadasan D; Sultan MH; Alqahtani SS; Javed S
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189732
[TBL] [Abstract][Full Text] [Related]
23. Nanostructured cubosomes as a platform for oral drug delivery.
Liu M; Chen M; Xu P; Yang Z
Curr Pharm Biotechnol; 2015; 16(4):313-21. PubMed ID: 25601599
[TBL] [Abstract][Full Text] [Related]
24. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.
Zhai J; Waddington L; Wooster TJ; Aguilar MI; Boyd BJ
Langmuir; 2011 Dec; 27(24):14757-66. PubMed ID: 22026367
[TBL] [Abstract][Full Text] [Related]
25. Metallo-Cubosomes: Zinc-Functionalized Cubic Nanoparticles for Therapeutic Nucleotide Delivery.
Tajik-Ahmadabad B; Chollet L; White J; Separovic F; Polyzos A
Mol Pharm; 2019 Mar; 16(3):978-986. PubMed ID: 30648870
[TBL] [Abstract][Full Text] [Related]
26. Impact of preparation method and variables on the internal structure, morphology, and presence of liposomes in phytantriol-Pluronic(®) F127 cubosomes.
Akhlaghi SP; Ribeiro IR; Boyd BJ; Loh W
Colloids Surf B Biointerfaces; 2016 Sep; 145():845-853. PubMed ID: 27315333
[TBL] [Abstract][Full Text] [Related]
27. Nanostructured cubosomes as advanced drug delivery system.
Pan X; Han K; Peng X; Yang Z; Qin L; Zhu C; Huang X; Shi X; Dian L; Lu M; Wu C
Curr Pharm Des; 2013; 19(35):6290-7. PubMed ID: 23470001
[TBL] [Abstract][Full Text] [Related]
28. Topical Delivery of Erythromycin Through Cubosomes for Acne.
Khan S; Jain P; Jain S; Jain R; Bhargava S; Jain A
Pharm Nanotechnol; 2018; 6(1):38-47. PubMed ID: 29424323
[TBL] [Abstract][Full Text] [Related]
29. Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.
Rarokar NR; Saoji SD; Raut NA; Taksande JB; Khedekar PB; Dave VS
AAPS PharmSciTech; 2016 Apr; 17(2):436-45. PubMed ID: 26208439
[TBL] [Abstract][Full Text] [Related]
30. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management.
Zewail M; E Gaafar PM; Ali MM; Abbas H
Drug Deliv; 2022 Dec; 29(1):1663-1674. PubMed ID: 35616281
[TBL] [Abstract][Full Text] [Related]
31. Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy.
Singh S; Sachan K; Verma S; Singh N; Singh PK
Curr Pharm Biotechnol; 2024; 25(6):757-771. PubMed ID: 37929730
[TBL] [Abstract][Full Text] [Related]
32. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Luo Q; Lin T; Zhang CY; Zhu T; Wang L; Ji Z; Jia B; Ge T; Peng D; Chen W
Int J Pharm; 2015 Sep; 493(1-2):30-9. PubMed ID: 26209071
[TBL] [Abstract][Full Text] [Related]
33. Comparison of cubosomes and liposomes for the encapsulation and delivery of curcumin.
Chang C; Meikle TG; Drummond CJ; Yang Y; Conn CE
Soft Matter; 2021 Mar; 17(12):3306-3313. PubMed ID: 33623948
[TBL] [Abstract][Full Text] [Related]
34. Remote Loading of Hydrophilic Drug into Cubosomes by Transmembrane pH-Gradient and Characterization of Drug-Loaded Cubosomes Prepared by Different Method.
Zeng L; Ke Y; Zheng C; Song H; Liu Z; Hu X; Zhou X
J Pharm Sci; 2023 Apr; 112(4):1119-1129. PubMed ID: 36596394
[TBL] [Abstract][Full Text] [Related]
35. Cubosomes as Oral Drug Delivery Systems: A Promising Approach for Enhancing the Release of Clopidogrel Bisulphate in the Intestine.
El-Laithy HM; Badawi A; Abdelmalak NS; El-Sayyad N
Chem Pharm Bull (Tokyo); 2018 Dec; 66(12):1165-1173. PubMed ID: 30232306
[TBL] [Abstract][Full Text] [Related]
36. Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.
Kathe N; Henriksen B; Chauhan H
Drug Dev Ind Pharm; 2014 Dec; 40(12):1565-75. PubMed ID: 24766553
[TBL] [Abstract][Full Text] [Related]
37. Formulation, In-Vitro and Ex-Vivo Evaluation of Tretinoin Loaded Cubosomal Gel for the Treatment of Acne.
Sureka S; Gupta G; Agarwal M; Mishra A; K Singh S; P Singh R; Sah SK; de Jesus A Pinto T; Dua K
Recent Pat Drug Deliv Formul; 2018; 12(2):121-129. PubMed ID: 29437029
[TBL] [Abstract][Full Text] [Related]
38. Cancer-cell-targeted theranostic cubosomes.
Caltagirone C; Falchi AM; Lampis S; Lippolis V; Meli V; Monduzzi M; Prodi L; Schmidt J; Sgarzi M; Talmon Y; Bizzarri R; Murgia S
Langmuir; 2014 Jun; 30(21):6228-36. PubMed ID: 24815031
[TBL] [Abstract][Full Text] [Related]
39. The cubosome-based nanoplatforms in cancer therapy: Seeking new paradigms for cancer theranostics.
Gowda BHJ; Ahmed MG; Alshehri SA; Wahab S; Vora LK; Singh Thakur RR; Kesharwani P
Environ Res; 2023 Nov; 237(Pt 1):116894. PubMed ID: 37586450
[TBL] [Abstract][Full Text] [Related]
40. Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications.
Murgia S; Falchi AM; Meli V; Schillén K; Lippolis V; Monduzzi M; Rosa A; Schmidt J; Talmon Y; Bizzarri R; Caltagirone C
Colloids Surf B Biointerfaces; 2015 May; 129():87-94. PubMed ID: 25829131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]